Prophylactic Efficacy of Allopurinol Ice Ball for Leucovorin/ 5-Fluorouracil Therapy-induced Stomatitis

Anticancer Research

Volumn 24, Issue 2 C, 2004, Pages 1131-1134

  Yokomizo, Hajime ^a   Yoshimatsu, Kazuhiko ^a   Hashimoto, Masahiko ^a   Ishibashi, Keiichiro ^a   Umehara, Arihiro ^a   Yoshida, Kiyohito ^a   Fujimoto, Takashi ^a   Watanabe, Kiyo ^a   Ogawa, Kenji ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Allopurinol cryotherapy; Cancer chemotherapy; LV 5 FU; Stomatitis

Indexed keywords

ALLOPURINOL; FLUOROURACIL; FOLINIC ACID;

ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COLON CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG FORMULATION; DRUG WITHDRAWAL; HUMAN; PREVENTIVE MEDICINE; PRIORITY JOURNAL; QUALITY OF LIFE; STOMATITIS; TREATMENT OUTCOME;

ALLOPURINOL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLONIC NEOPLASMS; FLUOROURACIL; HUMANS; HYPOTHERMIA, INDUCED; ICE; LEUCOVORIN; STOMATITIS;

EID: 2442615146     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Poon MA, O'Connel MJ, Moertel CG, Wiend HS, Cullinan SA, Everson LK, Krook JE, Mailliard JA, Laurie JA, Tschetter LK et al: Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol 7: 1407-1418, 1989.
2. Umehara A, Kato H, Takahashi N, Endo S, Yoshimatsu K, Hashimoto M, Haga S and Kajiwara T: A case of recurrent colon cancer with complete response to modulation chemotherapy using low-dose leucovorin and 5-fluorouracil. Jpn J Cancer Chemother 26: 1189-1192, 1999. (in Japanese with English abstract)
3. Coates A, Abraham S, Kaye SB, Sowerbutts T, Frewn C, Fox RM and Tattersall MH: On the receiving end-patients perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol 19: 203-208, 1983.
4. Pferiffer O, Madsen EL, Hansen O and May O: Effect of prophylactic sucralfate suspension on stomatatis induced by chemotherapy: a randomized, double-blind cross-over study. Acta Oncolo 29: 171-173, 1990.
5. Porteder H, Rausch E, Kmant G, Watzek G, Matejka M and Sinzinger H: Local prostaglandin E2 in patients with oral malignancies undergoing chemo- and radiotherapy. J Craniomaxillofac Surg 16: 371-374, 1988.
6. Clark PI and Slevin ML: Allopurinol mouthwashes and 5-fluorouracil induced oral toxicity. Eur J Surg Oncol 11: 267-268, 1985.
7. Dozono H, Nakamura K, Motoya T, Nakamura S, Shinmura R, Miwa K, Ishibashi M and Nagata Y: The prevention of stomatitis induced by anti-cancer drugs. Jpn J Cancer Chemother 16: 3449-3451, 1989. (in Japanese with English abstract)
8. Elzawawy A: Treatment of 5-fluorouracil-induced stomatitis by allopurinol mouthwashes. Oncology 48: 282-284, 1991.
9. Porta C, Moroni M and Nastasi G: Allopurinol mouthwashes in the treatment of 5-fluorouracil-induced stomatitis. Am J Clin Oncol 17: 246-247, 1994.
10. Mahood DJ, Dose AM, Loprinzi CL, Veeder MH, Athmann LM, Therneau TM, Sorensen JM, Gainey DK, Maillard JA and Gusa NL: Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol 9: 449-452, 1991.
11. Pourreau-Schneider N, Soudry M, Franquin JC, Zattara H, Martin PM, Ciais G, Namer M, Schneider M, Chauvel P and Demard F: Soft-laser therapy for iatrogenic mucositis in cancer patients receiving high-dose fluorouracil: a preliminary report. J Natl Cancer Inst 84: 358-359, 1992.
12. Grading of toxicity. In: Manual of Oncologic Therapeutics 1991/1992. (Wittes RE ed.) 445-448. Philadelphia. Lippincott. 1991.
13. Douglas EP: Oral toxicity of chemotherapeutic agents. Semin Oncol 19: 478-491, 1992.
14. Peterson DE: Pretreatment strategies for infection prevention in chemotherapy patients. J Natl Cancer Inst Monogr 9: 61-71, 1990.
15. Verdi CJ: Cancer therapy and oral mucositis. An appraisal of drug prophylaxis. Drug Safety 9: 185-195, 1993.
16. Nakamura K, Natsugoe S, Kumanohoso T, Shinkawa T, Kariyazono H, Yamada K, Baba M, Oshinaka H, Fukumoto T and Aikou T: Prophylactic action of allopurinol against chemotherapy-induced stomatatis. Inhibition of superoxide dismutase and proteases. Anticancer Drugs 7: 235-239, 1996.
17. Schwartz PM and Handschumacher RE: Selective antagonism of 5-fluorouracil cytotoxicity by 4-hydroxypyrazolopyrimidine (allopurinol) in vitro. Cancer Res 39: 3095-3101, 1979.
18. Schwartz PM, Duningan JM, Harsh JC and Hanschumacher RE: Allopurinol modification of the toxicity and antitumor activity of 5-fluorouracil. Cancer Res 40: 1885-1889, 1980.
19. Reyes P and Guganig ME: Studies on a pyrimidine phosphoribosyltransferase from murine leukemia P.1534J. J Biol Chem 250: 5097-5108, 1975.
20. Howell SB, Wung WE, Taetle R, Hussain F and Romine JS: Modulation of 5-fluorouracil toxicity by allopurinol in man. Cancer 48: 1281-1289, 1981.